| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,133 |
800 |
$53K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
472 |
352 |
$13K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
309 |
243 |
$10K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
264 |
159 |
$7K |
| 80053 |
Comprehensive metabolic panel |
324 |
283 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
99 |
71 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
140 |
128 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
61 |
52 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
37 |
28 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
199 |
88 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
360 |
311 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
42 |
38 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
15 |
$1K |
| 80061 |
Lipid panel |
82 |
75 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
37 |
28 |
$700.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15 |
13 |
$585.60 |
| 36000 |
|
82 |
66 |
$497.84 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
83 |
76 |
$469.70 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
17 |
12 |
$315.57 |
| 81003 |
|
13 |
12 |
$40.70 |
| 3016F |
|
14 |
14 |
$0.00 |
| 1090F |
|
28 |
28 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
28 |
28 |
$0.00 |
| 3288F |
|
15 |
15 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
29 |
29 |
$0.00 |
| 3725F |
|
28 |
28 |
$0.00 |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
38 |
35 |
$0.00 |
| 1159F |
|
27 |
27 |
$0.00 |
| 1124F |
|
14 |
14 |
$0.00 |
| 1170F |
|
28 |
28 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
76 |
55 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
83 |
27 |
$0.00 |
| 1101F |
|
15 |
15 |
$0.00 |
| 3044F |
|
24 |
24 |
$0.00 |
| 3008F |
|
15 |
15 |
$0.00 |